Ectopic addition of IL-6 rescued cancer cell migration, proliferation, and invasion when Stattic was used as a monotherapy; however, combination with tocilizumab maintained inhibitory activity, even under high dose IL-6 stimulation [196]. The gene discussed is IL6; the disease is cancer.